Glenmark Pharmaceuticals Receives US FDA Approval for Fluticasone Propionate Nasal Spray
Glenmark Pharmaceuticals receives US Food and Drug Administration (FDA) approval for Fluticasone Propionate Nasal Spray, a bioequivalent and therapeutically equivalent generic of Flonase Nasal Spray.
Flonase Nasal Spray | 20/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy